ANDA 90685, held by Ppi-Dac. Polyethylene Glycol 3350.
As of Nov 16, 2026, ANDA 90685 (Polyethylene Glycol 3350), held by Ppi-Dac, was first approved by FDA on Oct 6, 2009, with 7 approved supplements and 0 published complete response letters.
Use
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 6, 2009 | Original application | Approved |
| Polyethylene Glycol 335017GM/PACKET · for solution;oral | Polyethylene Glycol 3350 | OTC |
| Polyethylene Glycol 335017GM/SCOOPFUL · for solution;oral | Polyethylene Glycol 3350 | OTC |
| Aug 18, 2026 | Supplement 19Manufacturing | Approved | None posted |
| Jun 16, 2022 | Supplement 14Manufacturing | Approved | None posted |
| Oct 13, 2021 | Supplement 11Labeling · Standard review | Approved | None posted |
| Oct 13, 2021 | Supplement 13Labeling · Standard review | Approved | None posted |
| Oct 11, 2019 | Supplement 9Manufacturing | Approved | None posted |
| Jan 12, 2016 | Supplement 3Labeling · Standard review | Approved | None posted |
| Feb 6, 2013 | Supplement 2Labeling | Approved | None posted |
| Oct 6, 2009 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters